Zussanil 40mg Tablet contains Esomeprazole 40mg, a proton pump inhibitor (PPI) indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and other conditions involving excessive stomach acid production. Esomeprazole works by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing gastric acid secretion. This reduction in acid helps promote healing of acid-related damage to the esophagus and stomach lining, alleviating symptoms such as heartburn, acid regurgitation, and dyspepsia. Zussanil is also used in combination with antibiotics for the eradication of Helicobacter pylori infection to reduce the risk of duodenal ulcer recurrence. The recommended dosage and duration of therapy depend on the specific indication and patient response, and it should be administered orally, preferably before meals. Patients with known hypersensitivity to Esomeprazole or other PPIs should avoid this medication. Caution is advised in patients with hepatic impairment, and long-term use may require monitoring for potential adverse effects such as vitamin B12 deficiency, hypomagnesemia, or increased risk of bone fractures. Consultation with a healthcare professional is essential before initiating therapy with Zussanil 40mg Tablet.